New clinical trial shows that a new catheter-based treatment of high blood pressure leads to a significant and sustainable decrease of in blood pressure Leipzig, December 2, 2010: that high blood pressure can lead to stroke and heart attack and thus in the worst case to death, is well known. Clear that the kidneys in the regulation of blood pressure in the body play a central role, however, is so far only a few people. Current study data show that a new minimally invasive catheter procedures can lead to a lower blood pressure. Results from a large-scale study to this new treatment for high blood pressure were a few days ago for the first time in the context of the American Heart Association scientific sessions 2010″presented and at the same time in the prestigious journal the Lancet ‘ published. Only 24 clinical centers around the world were able to get on this ground-breaking study involved including the Centre for vascular medicine of at Park Hospital in Leipzig. Under the direction of Prof.
Dr. med. Dierk SAEI, chief physician of the clinic for internal I medicine and Medical Director of the Hospital belonging to the RHoN-KLINIKUM AG, were included eight patients in this clinical study. Since then, 25 more patients have been treated with this new catheterization procedures in the local Centre for vascular medicine today. Within this study, a total of 106 patients in Europe and Australia were treated with a special catheter procedure that sets targeted high-frequency low current pulses in the vessel wall of the renal arteries to disable the trending towards brain nerves there. Through the targeted switch-off in high blood pressure patients usually hyperactive sympathetic nervous system, a significant reduction in blood pressure was detected also at Leipzig Park Hospital. After six months he has reduced himself to 32/12 mmHg, while he mmHg in the control group, which alone was been medication, rose to 1/0.
Not logged in